Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KP-1019

Known as: KP 1019, KP1019 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Ruthenium(III) complexes are promising candidates for anticancer drugs, especially the clinically studied indazolium trans… Expand
2013
2013
Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (1, KP1019) and its analogue sodium trans-[tetrachlorobis(1H… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Highly Cited
2012
Highly Cited
2012
Indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1019) and its Na+ analogue (KP1339) are two of the most… Expand
  • figure 3
  • table 1
  • figure 1
  • figure 2
  • figure 4
Highly Cited
2011
Highly Cited
2011
The cellular uptake and subcellular distribution including adduct formation with genomic DNA and uptake into mitochondria of two… Expand
  • figure 1
Highly Cited
2010
Highly Cited
2010
The ruthenium compound KP1019 has demonstrated promising anticancer activity in a pilot clinical trial. This study aims to… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2010
Highly Cited
2010
The binding of the ruthenium-based anticancer drug candidates KP1019, NAMI-A and RAPTA-T towards different double-stranded… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
A phase I and pharmacokinetic study was carried out with the new ruthenium complex indazolium trans-[tetrachlorobis(1H-indazole… Expand
Highly Cited
2009
Highly Cited
2009
The compounds imidazolium [trans-[RuCl4(1H-imidazole)2] (KP418) and indazolium [trans-RuCl4(1H-indazole)2] (KP1019) both show… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 6
  • figure 7
Highly Cited
2005
Highly Cited
2005
KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A) is a metal complex with promising anticancer… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
2004
Highly Cited
2004
Purpose The ruthenium complex salt indazolium trans-[tetrachlorobisindazole-ruthenate(III)] (KP1019) and the analogous sodium… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1